Avenue Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Avenue Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ATXI | Avenue Therapeutics | -$1.92 | — | — | — | $0.00 | — | — | — | 11/13/2025 | |
ATXI | Avenue Therapeutics | -$6.43 | — | $0.11 | — | $0.00 | — | $1.40M | — | 08/14/2025 | |
ATXI | Avenue Therapeutics | -$15.40 | — | -$0.62 | — | $0.00 | — | $0.00 | — | 05/15/2025 | |
ATXI | Avenue Therapeutics | $2.25 | — | $1.48 | — | $0.00 | — | $0.00 | — | 03/31/2025 | |
ATXI | Avenue Therapeutics | $4.50 | -$0.94 | -$1.92 | -104.26% | $0.00 | — | $0.00 | — | 11/14/2024 | |
ATXI | Avenue Therapeutics | -$39.00 | -$1.05 | -$6.43 | -512.38% | $0.00 | — | $0.00 | — | 08/09/2024 | |
ATXI | Avenue Therapeutics | -$102.75 | -$9.00 | -$15.40 | -71.11% | $0.00 | — | $0.00 | — | 05/15/2024 | |
ATXI | Avenue Therapeutics | -$92.25 | -$7.50 | $2.25 | 130.00% | $0.00 | — | $0.00 | — | 03/18/2024 | |
ATXI | Avenue Therapeutics | -$33.75 | -$19.50 | $4.50 | 123.08% | $0.00 | — | $0.00 | — | 11/13/2023 | |
ATXI | Avenue Therapeutics | -$33.75 | -$21.75 | -$39.00 | -79.31% | $0.00 | — | $0.00 | — | 08/10/2023 | |
ATXI | Avenue Therapeutics | -$157.50 | — | -$102.75 | — | $0.00 | — | $0.00 | — | 05/12/2023 | |
ATXI | Avenue Therapeutics | -$56.25 | — | -$92.25 | — | $0.00 | — | $0.00 | — | 03/30/2023 | |
ATXI | Avenue Therapeutics | -$56.25 | — | -$33.75 | — | $0.00 | — | $0.00 | — | 11/10/2022 | |
ATXI | Avenue Therapeutics | -$67.50 | — | -$33.75 | — | $0.00 | — | $0.00 | — | 08/15/2022 | |
ATXI | Avenue Therapeutics | -$67.50 | — | -$157.50 | — | $0.00 | — | $0.00 | — | 05/16/2022 | |
ATXI | Avenue Therapeutics | -$67.50 | — | -$56.25 | — | $0.00 | — | $0.00 | — | 03/25/2022 | |
ATXI | Avenue Therapeutics | -$67.50 | -$56.25 | -$56.25 | 0.00% | $0.00 | — | $0.00 | — | 11/15/2021 | |
ATXI | Avenue Therapeutics | -$123.75 | — | -$67.50 | — | $0.00 | — | $0.00 | — | 08/16/2021 | |
ATXI | Avenue Therapeutics | -$90.00 | — | -$67.50 | — | $0.00 | — | $0.00 | — | 05/17/2021 | |
ATXI | Avenue Therapeutics | -$371.25 | -$78.75 | -$67.50 | 14.29% | $0.00 | — | $0.00 | — | 03/31/2021 | |
ATXI | Avenue Therapeutics | -$157.50 | — | -$67.50 | — | $0.00 | — | $0.00 | — | 11/04/2020 |
Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
---|---|---|---|---|
Q3 | 2024-11-14 | $-1.92 | $-0.94 | -104.3 % |
Q2 | 2024-08-09 | $-6.43 | $-1.05 | -512.4 % |
Q1 | 2024-05-15 | $-15.40 | $-9.00 | -71.1 % |
Q4 | 2024-03-18 | $2.25 | $-7.50 | 130.0 % |
Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
---|---|---|---|---|
Está previsto que Avenue Therapeutics (ATXI) presente resultados el noviembre 13, 2025. Los últimos resultados se publicaron el agosto 14, 2025 para el Q2.
El BPA real fue de $0.11, que superó la estimación de $0.00.
Los ingresos reales fueron $1.4M, que superó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.